Minzel-DSR Capsules contain Rabeprazole Sodium (EC) and Domperidone (SR), a combination formulated to help manage acidity, acid reflux, heartburn and associated digestive symptoms. The product is marketed by Minzel Pharma.
Minzel-DSR Capsules contain a combination of Rabeprazole Sodium (EC) and Domperidone (SR). This formulation combines an acid-reducing medicine with a prokinetic agent to support the management of acid-related and associated gastrointestinal symptoms.
Rabeprazole is a proton pump inhibitor (PPI) that reduces the production of stomach acid. Domperidone helps improve gastrointestinal motility and may help with symptoms such as nausea and fullness when associated with certain digestive conditions.
Minzel-DSR may be prescribed for conditions involving acid reflux, heartburn, acidity and related gastrointestinal symptoms, depending on the patient's clinical condition.
